Category: Latest News
-
Oil prices hold steady but remain on course for strong weekly gains as U.S.-Iran conflict escalates
Oil prices traded modestly higher on Friday, with both major benchmarks set to record substantial weekly gains as escalating military action between the United States and Iran continued to raise concerns over potential supply disruptions in the Middle East. At 04:10 ET (08:10 GMT), Brent crude futures climbed 0.2% to $84.38 a barrel, while U.S.…
-
U.S. futures weaken as Netflix guidance disappoints and Middle East tensions intensify: Dow Jones, S&P, Nasdaq, Wall Street
U.S. stock index futures traded lower on Friday as investors remained cautious about the outlook for artificial intelligence spending while monitoring renewed military escalation between the United States and Iran. By 02:57 ET (06:57 GMT), Dow Jones futures had fallen 336 points, or 0.6%, S&P 500 futures were down 66 points, or 0.9%, and Nasdaq…
-
Nasdaq Tumbles 1.5% as Chip Stocks Slide on AI Spending Worries, Dow Holds Steady
Wall Street closed lower on Thursday as a renewed sell-off in semiconductor stocks dragged the Nasdaq Composite down sharply, even as strong earnings from healthcare names helped keep the Dow Jones Industrial Average close to flat. Investors spent the session digesting a wave of second-quarter earnings while growing more cautious about the pace and cost…
-
Rubico Estimates Net Asset Value at $183.1 Million, Up 94% From Previous NAV (NASDAQ:RUBI)
Rubico announced a management estimate of its net asset value of $183.1 million as of June 30, 2026, driven by updated vessel valuations and representing a 94% increase from its previously reported NAV. Key Investor Takeaways Why RUBI Stock Is in Focus Rubico released a new management estimate placing its net asset value at $183.1…
-
Galmed Develops Cardiac-Targeted Aramchol Formulation to Expand Cardiovascular Pipeline (NASDAQ:GLMD)
Galmed announced the development of a lipid nanoparticle formulation of Aramchol designed to target heart tissue, marking a potential expansion of the drug beyond its existing liver and gastrointestinal development programs. Key Investor Takeaways Why GLMD Stock Is in Focus Galmed announced a new lipid nanoparticle (LNP) formulation of its SCD1 inhibitor Aramchol that is…
-
American Fusion Announces Texatron Fusion Engine Presentation at Fermilab Conference
American Fusion said Chief Technology Officer Dr. John Brandenburg will present the company’s Texatron Fusion Engine technology at a scientific conference hosted at Fermilab, outlining its development progress and future testing plans. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion announced that CTO Dr. John Brandenburg is scheduled to present the company’s…
-
BioAdaptives Outlines Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives detailed the strategy behind its Xcellara platform, combining stem cell mobilization with tissue-targeting technology as it prepares to launch XcellaraHeart on August 1, 2026. Key Investor Takeaways Why BDTP Stock Is in Focus BioAdaptives outlined the development strategy behind its Xcellara cellular wellness platform as it approaches the August 1, 2026 commercial launch of…
-
IQSTEL Reports First-Half 2026 Revenue Growth of 59%, Targets $500 Million Annual Revenue Run Rate
IQSTEL reported preliminary first-half 2026 revenue of approximately $207 million, while the pending Ultranet acquisition is expected to increase both the company’s revenue scale and profitability. Key Investor Takeaways Why IQST Stock Is in Focus IQSTEL announced preliminary net revenue of approximately $207 million for the first six months of 2026, representing a 59% increase…
-
Micron secures long-term automotive supply deals with seven technology partners (MU)
Strategic agreements strengthen future automotive chip supply Micron Technology (NASDAQ:MU) has entered into Strategic Customer Agreements (SCAs) with seven leading automotive technology companies to help secure long-term supplies of memory and storage products for next-generation vehicle platforms. The agreements include Qualcomm, Visteon, HARMAN, JOYNEXT, DENSO, Astemo and Hyundai Mobis, all of which are major Tier…
-
CareDx shares jump as Medicare finalizes transplant testing coverage policy (CDNA)
Final Medicare policy supports transplant surveillance portfolio CareDx Inc. (NASDAQ:CDNA) shares climbed 20% on Thursday after the company announced that Medicare had finalized its Local Coverage Determination (LCD) covering molecular testing for solid organ transplant rejection. The finalized policy confirms Medicare coverage for CareDx’s transplant surveillance tests used in kidney, heart and lung transplant patients,…